To include your compound in the COVID-19 Resource Center, submit it here.

A new hat trick

VC Hatteras earmarks 20% of new fund for high-risk early biopharma projects

A new hat trick

Early stage VC Hatteras Venture Partners announced a first close of its fourth fund, raising $74 million of a planned of $125 million that will be invested in fledgling companies. The firm said 20% of the fund

Read the full 409 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers